ID   Regea08/023
AC   CVCL_B360
SY   Regea 08/023; UTAe007-A
DR   hPSCreg; UTAe007-A
DR   ISCR; 1397
DR   SKIP; SKIP002340
DR   Wikidata; Q54949715
RX   PubMed=20177999;
RX   PubMed=23341440;
CC   From: Regea Institute for Regenerative Medicine; Tampere; Finland.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
RX   PubMed=20177999; DOI=10.1007/s11626-010-9286-2;
RA   Skottman H.;
RT   "Derivation and characterization of three new human embryonic stem
RT   cell lines in Finland.";
RL   In Vitro Cell. Dev. Biol. Anim. 46:206-209(2010).
//
RX   PubMed=23341440; DOI=10.5966/sctm.2012-0047;
RA   Toivonen S., Ojala M., Hyysalo A., Ilmarinen T., Rajala K.,
RA   Pekkanen-Mattila M., Aanismaa R., Lundin K., Palgi J., Weltner J.,
RA   Trokovic R., Silvennoinen O., Skottman H., Narkilahti S.,
RA   Aalto-Setala K., Otonkoski T.;
RT   "Comparative analysis of targeted differentiation of human induced
RT   pluripotent stem cells (hiPSCs) and human embryonic stem cells reveals
RT   variability associated with incomplete transgene silencing in
RT   retrovirally derived hiPSC lines.";
RL   Stem Cells Transl. Med. 2:83-93(2013).
//